This test encompasses 51 EGFR clinically relevant mutations from exons 18 to 21 in human lung cancer FFPE material (according to the latest IASLC atlas of EGFR testing in lung cancer) [21]. The gene discussed is EGFR; the disease is lung carcinoma.